BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 17030275)

  • 21. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
    Mooney MM
    J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of gastroesophageal tumors.
    Gee DW; Rattner DW
    Oncologist; 2007 Feb; 12(2):175-85. PubMed ID: 17296813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y; Sasako M; Doki Y
    Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of the esophago-gastric junction adenocarcinoma].
    Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multimodality therapy for adenocarcinoma of the esophagogastric junction].
    He J; Huang JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):877-80. PubMed ID: 22990915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
    Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
    Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
    Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Mason DP; Rodriguez CP; Ives DI
    J Thorac Oncol; 2009 Oct; 4(10):1264-9. PubMed ID: 19668013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.
    DeMeester SR
    Ann Surg Oncol; 2006 Jan; 13(1):12-30. PubMed ID: 16378161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

  • 32. Adenocarcinoma of the proximal esophagus: report of 9 patients and review of the literature.
    Marano S; Ruol A; Castoro C; Portale G; Cagol M; Alfieri R; Michieletto S; Ancona E
    Ann Surg Oncol; 2008 Oct; 15(10):2910-4. PubMed ID: 18696159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY; Ilson DH
    Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.
    Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Burmeister B; Kelsen D; Niedzwiecki D; Schuhmacher C; Urba S; van de Velde C; Walsh TN; Ychou M; Jensen K
    Eur J Cancer; 2013 Oct; 49(15):3149-58. PubMed ID: 23800671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality therapy of esophageal cancer: an update.
    Kelsen DP
    Cancer J; 2000 Apr; 6 Suppl 2():S177-81. PubMed ID: 10803833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma.
    Blazeby JM; Sanford E; Falk SJ; Alderson D; Donovan JL
    Cancer; 2005 May; 103(9):1791-9. PubMed ID: 15779022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.
    Kleinberg L; Brock M; Gibson M
    Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of adenocarcinoma extending to the middle and upper part of the esophagus.
    Hiatt JR; Williams RA; Stabile BE; Wilson SE
    Surg Gynecol Obstet; 1984 Jun; 158(6):541-4. PubMed ID: 6203180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
    Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
    Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.